X
19
Fougera Pharmaceuticals Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BETAMETHASONE DIPROPIONATE, with a corresponding application number 75276 and regulatory information .
proudly manufactured in the
approval since 2003-05-13
Fougera Pharmaceuticals Inc.'s BETAMETHASONE DIPROPIONATE GEL, AUGMENTED;TOPICAL, medication with EQ 0.05% BASE of BETAMETHASONE DIPROPIONATE.